New Delhi, August 31
Days after the national drug regulator granted market authorisation approval to the first indigenous vaccine for cervical cancer and makers Serum Institute of India told the Health Ministry it would supply one crore doses for the national immunisation programme by December this year, the government is all set to announce the HPV shot launch on Thursday.
Prior to the approval by the Drug Controller General of India, the National Technical Advisory Group for Immunisation had looked at the SII’s data for the shot and approved its inclusion in the national immunisation plan.
The ministry is planning to roll out the shot — the indigenously developed quadrivalent human papillomavirus vaccine (qHPV) — by year end with Minister of Science and Technology Jitendra Singh all set to announce its launch for the prevention of cervical cancer tomorrow.
The Tribune News Service brings you the latest news, analysis and insights from the region, India and around the world. Follow the Tribune News Service for a wide-ranging coverage of events as they unfold, with perspective and clarity.
Join Whatsapp Channel of The Tribune for latest updates.
Most Read In 24 Hours
Don't Miss
View All
Top News
Israel attacks Iran's air base, sources say, drones reported over Isfahan
Iran fires air defence batteries at Isfahan air base and nuc...
2 Indian-origin men among 6 arrested in Canada's biggest-ever heist; Here is how $22.5 million were robbed from Toronto's main airport
Two persons of Indian origin--Parmpal Sidhu, 54, and Amit Ja...
Lok Sabha elections 2024: Voting under way for 102 seats in Phase 1
Polling for assembly elections in the north-eastern states o...
Central Consumer Protection Authority asks FSSAI to probe claim of Nestle adding sugar to baby products
The National Commission for Protection of Child Rights (NCPC...
